Practical management of patients with IDH-mutant glioma in the coming era of mIDH inhibitors: New drugs, new evidence, new guidelines, and new considerations

Katherine B. Peters; Marjolein Geurts

doi:10.1093/nop/npae076

Practical management of patients with IDH-mutant glioma in the coming era of mIDH inhibitors: New drugs, new evidence, new guidelines, and new considerations

Katherine B. Peters^*, Marjolein Geurts

^*Corresponding author for this work

Neurology

Research output: Contribution to journal › Editorial › Academic › peer-review

Original language	English
Number of pages	4
Journal	Neuro-Oncology Practice
DOIs	https://doi.org/10.1093/nop/npae076
Publication status	Published - 19 Oct 2024

Access to Document

10.1093/nop/npae076

Cite this

@article{eef138d3bd8642aebd6db960a998bade,

title = "Practical management of patients with IDH-mutant glioma in the coming era of mIDH inhibitors: New drugs, new evidence, new guidelines, and new considerations",

author = "Peters, {Katherine B.} and Marjolein Geurts",

year = "2024",

month = oct,

day = "19",

doi = "10.1093/nop/npae076",

language = "English",

journal = "Neuro-Oncology Practice",

issn = "2054-2577",

publisher = "Oxford University Press",

}

TY - JOUR

T1 - Practical management of patients with IDH-mutant glioma in the coming era of mIDH inhibitors

T2 - New drugs, new evidence, new guidelines, and new considerations

AU - Peters, Katherine B.

AU - Geurts, Marjolein

PY - 2024/10/19

Y1 - 2024/10/19

UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=eur_pure&SrcAuth=WosAPI&KeyUT=WOS:001337893700001&DestLinkType=FullRecord&DestApp=WOS_CPL

U2 - 10.1093/nop/npae076

DO - 10.1093/nop/npae076

M3 - Editorial

SN - 2054-2577

JO - Neuro-Oncology Practice

JF - Neuro-Oncology Practice

ER -

Practical management of patients with IDH-mutant glioma in the coming era of mIDH inhibitors: New drugs, new evidence, new guidelines, and new considerations

Access to Document

Other files and links

Cite this